Covishield and Covaxin approved for emergency use as COVID vaccines

Covishield and Covaxin approved for emergency use as COVID vaccines

The Central Drugs and Standards Committee (CDSCO) formally approved the COVID-19 vaccines by Bharat Biotech and the Serum Institute of India (SII).
This allows the vaccines — Covishield by SII and based on the Oxford AstraZeneca vaccine, and Covaxin by Bharat Biotech — to be offered to healthcare workers and frontline workers in India.
The Health Ministry had said that 3 crore such personnel, considered at the highest risk for COVID-19, would be given the vaccine for free.
Neither Covishield nor Covaxin has completed the crucial Phase-3 trial, under which a vaccine candidate is administered to volunteers at multiple locations across the country.
Both approvals accorded are for “restricted use in emergency situation” and in the case of Bharat Biotech, the approval wording notes that it is in “...public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains”. These conditions were not specified.

The Central Drugs Standard Control Organisation (CDSCO)

CDSCO under Directorate General of Health Services, Ministry of Health and Family Welfare is the National Regulatory Authority (NRA) of India.
Functions: Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of New Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice.
CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.

Source: TH

Join Our Telegram

Bird Flu in India

Income Tax Dept. to crack down on GST fraud

E-pharmacies

08 Mar, 23
SHARE

E-pharmacies The Ministry of Health sent "show cause" letters to at least 20 businesses in February 2023 for online drug sales, including Tata-1mg, Flipkart, Apollo, PharmEasy, Amazon, and Reliance Netmeds. What is e-pharmacy? E-pharmacy refers to the purchasing and selling of drugs and other pharmaceutical products through a

Punchhi Commission Report

08 Mar, 23
SHARE

Punchhi Commission Report The Punchhi Commission's report on relations between the federal government and its constituent states will now be reviewed for state responses, according to the Union Ministry of Home Affairs (MHA). Historical Background: A Commission on Centre-State Relations was established by the Indian government,

Indo-German Relations

08 Mar, 23
SHARE

Indo-German Relations Olaf Scholz, the Chancellor of Germany, recently paid a bilateral visit to India. It is Scholz's first trip to India after taking office as German Chancellor in December 2021, ending Angela Merkel's illustrious 16-year reign. About the news: The visit of the German chancellor is significant because i

India Denmark Cooperation

07 Mar, 23
SHARE

India Denmark Cooperation During the "India-Denmark: Partners for Green and Sustainable Development Conference" in New Delhi, the Union Minister for Environment, Forests, and Climate Change said that India and Denmark can work together to show that reaching ambitious climate and sustainable energy targets is possible. Since the Gr

Mob lynching and Cow Vigilantism

07 Mar, 23
SHARE

Mob lynching and Cow Vigilantism The recent lynching and burning of two men in Haryana on the basis of allegations of unlawful cow slaughter, smuggling, or transportation bring attention to the problem of mob lynching. About cow vigilantism: Mob attacks carried out in the guise of "cow protection" primarily target Mus